SP-MHCI-0400-2

Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI

US$169.00

In stock

Description

About Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI

The Murid herpesvirus 1 (strain Smith) Ribonucleoside-diphosphate reductase large subunit-like protein Peptide (IEDB: 23911) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Ribonucleoside-diphosphate reductase Peptide, H-HGIRNASFI-OH (Uniprot: Q06A28 aa: 985-993) from JPT is produced under strict quality control and quality management.

Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI - Specifications

  • Peptide sequence: H-HGIRNASFI-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI

References:
Read References with JPT’s Antigen Peptides
Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI has been described in:
The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo., J Immunol, 2002 (PMID: 12077265)
Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection., J Immunol, 2007 (PMID: 17513772)
Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors., J Immunol Methods, 1997 (PMID: 9502585)

Documentation

Documentation for Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI

Properties

Properties of Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Murid herpesvirus
Protein Name: Ribonucleoside-diphosphate reductase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Murid herpesvirus 1 (strain Smith) RIR1 985-993, HGIRNASFI

Information Values
Sequence: H-HGIRNASFI-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote